4.7 Article

A porous Cu(II)-based metal-organic framework carrier for pH-controlled anticancer drug delivery

Journal

INORGANIC CHEMISTRY COMMUNICATIONS
Volume 111, Issue -, Pages -

Publisher

ELSEVIER
DOI: 10.1016/j.inoche.2019.107675

Keywords

MOF; Drug carrier; MTT

Funding

  1. Public Research and Capacity Building Projects of Department of Guangdong Province [2017A010103022]
  2. Natural Science Foundation of China [51978415]
  3. Natural Science Foundation of Guangdong Province [2017A030313079]
  4. Featured Innovation Project of Guangdong Province [2017KTSCX083, 2018KTSCX083]
  5. Special Funds for Scientific Technological Innovation of Undergraduates in Guangdong Province [pdjha0218, pdjha0219, pdjha0226, pdjh2019b0215, pdjh2019b0222, pdjh2019b0219, pdjh2019b0221]
  6. Shenzhen Peacock Plan (Research and Development and Industrialization of in vitro Diagnostic Nanomaterials for Tumors) [KQTD2016022920325195]
  7. Science Foundation of Guangdong Medical University [GDMUM201821, ZYDM040, ZYDM041, ZYDM016, ZYDM017]
  8. Group-type Special Support Project for Education Talents in Universities [4SG19045G, 4SG19053G, 4SG19057G]
  9. Guangdong Medical University

Ask authors/readers for more resources

A new metal-organic framework with suitable channel size and good stability in biological buffer solution was investigated to load 5-fluorouracil (5-FU) though a simple adsorption process. The successful loading of 5-Fu was confirmed by the gas sorption measurement and the loading capacity was characterized by UV-Vis spectroscopy, which reveal a drug loading of 37.22%. The drug delivery in the simulated cancerous tissues (pH = 5.8 and 6.8) exhibited a more progressive release in comparison with that in the normal tissues (pH = 7.4), demonstrating a physiological pH-responsive drug release. Furthermore, as demonstrated by the MTT assay, this drug/MOF composite shows low cytotoxicity, good biocompatibility, and anticancer activity against cell lines A549 and HeLa. The result shows that 1 could be taken as a potential drug carrier.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.7
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available